Kenneth I Moch - Net Worth and Insider Trading

Kenneth I Moch Net Worth

The estimated net worth of Kenneth I Moch is at least $99,743 dollars as of 2024-05-25. Kenneth I Moch is the Director of Zynerba Pharmaceuticals Inc and owns about 75,778 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $98,511. Kenneth I Moch is also the President and CEO of Chimerix Inc and owns about 1,313 shares of Chimerix Inc (CMRX) stock worth over $1,232. Details can be seen in Kenneth I Moch's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kenneth I Moch has not made any transactions after 2023-06-14 and currently still holds the listed stock(s).

Transaction Summary of Kenneth I Moch

To

Kenneth I Moch Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kenneth I Moch owns 4 companies in total, including Zynerba Pharmaceuticals Inc (ZYNE) , Chimerix Inc (CMRX) , and Emisphere Technologies Inc (EMIS) among others .

Click here to see the complete history of Kenneth I Moch’s form 4 insider trades.

Insider Ownership Summary of Kenneth I Moch

Ticker Comapny Transaction Date Type of Owner
ZYNE Zynerba Pharmaceuticals Inc 2023-06-14 director
CMRX Chimerix Inc 2014-03-13 director & President and CEO
EMIS Emisphere Technologies Inc 2009-05-15 director
2022-01-01 director

Kenneth I Moch Latest Holdings Summary

Kenneth I Moch currently owns a total of 2 stocks. Among these stocks, Kenneth I Moch owns 75,778 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of June 14, 2023, with a value of $98,511 and a weighting of 98.77%. Kenneth I Moch also owns 1,313 shares of Chimerix Inc (CMRX) as of March 13, 2014, with a value of $1,232 and a weighting of 1.23%.

Latest Holdings of Kenneth I Moch

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZYNE Zynerba Pharmaceuticals Inc 2023-06-14 75,778 1.30 98,511
CMRX Chimerix Inc 2014-03-13 1,313 0.94 1,232

Holding Weightings of Kenneth I Moch


Kenneth I Moch Form 4 Trading Tracker

According to the SEC Form 4 filings, Kenneth I Moch has made a total of 2 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zynerba Pharmaceuticals Inc is the sale of 115 shares on June 14, 2023, which brought Kenneth I Moch around $40.

According to the SEC Form 4 filings, Kenneth I Moch has made a total of 0 transactions in Chimerix Inc (CMRX) over the past 5 years. The most-recent trade in Chimerix Inc is the sale of 18,979 shares on March 13, 2014, which brought Kenneth I Moch around $474,475.

Insider Trading History of Kenneth I Moch

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kenneth I Moch Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kenneth I Moch Ownership Network

Ownership Network List of Kenneth I Moch

No Data

Ownership Network Relation of Kenneth I Moch


Kenneth I Moch Owned Company Details

What does Zynerba Pharmaceuticals Inc do?

Who are the key executives at Zynerba Pharmaceuticals Inc?

Kenneth I Moch is the director of Zynerba Pharmaceuticals Inc. Other key executives at Zynerba Pharmaceuticals Inc include Chief Financial Officer James E Fickenscher , director & Chairman & Chief Exec. Officer Armando Anido , and President Terri B Sebree .

Zynerba Pharmaceuticals Inc (ZYNE) Insider Trades Summary

Over the past 18 months, Kenneth I Moch made 1 insider transaction in Zynerba Pharmaceuticals Inc (ZYNE) with a net sale of 115. Other recent insider transactions involving Zynerba Pharmaceuticals Inc (ZYNE) include a net sale of 53,283 shares made by Armando Anido , a net sale of 37,062 shares made by Terri B Sebree , and a net sale of 26,767 shares made by James E Fickenscher .

In summary, during the past 3 months, insiders sold 0 shares of Zynerba Pharmaceuticals Inc (ZYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 139,381 shares of Zynerba Pharmaceuticals Inc (ZYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 139,381 shares.

Zynerba Pharmaceuticals Inc (ZYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zynerba Pharmaceuticals Inc Insider Transactions

No Available Data

Kenneth I Moch Mailing Address

Above is the net worth, insider trading, and ownership report for Kenneth I Moch. You might contact Kenneth I Moch via mailing address: 68 Willow Ave, Larchmont Ny 10538.

Discussions on Kenneth I Moch

No discussions yet.